3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Keratosis, Actinic
3
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pelvic Neoplasms
1
Pain
1
Oropharyngeal Neoplasms
1
Neoplasms, Cystic, Mucinous, and Serous
1
Glioblastoma
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Brain Neoplasms
1
Agnosia
1
Interventions
pembrolizumab
7
Magnetic Resonance Spectroscopy
5
Cisplatin
5
Specimen Handling
4
Radiation
4
Radiotherapy
3
Biopsy
3
motexafin gadolinium
2
fludarabine
2
Vorinostat
2
Radiosurgery
2
Fluorouracil
2
Cyclophosphamide
2
zimberelimab
1
peposertib
1
ipatasertib
1
fludarabine phosphate
1
dl1520
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Platinum
1
Paclitaxel
1
Nivolumab
1
Lidocaine
1
L 778,123
1
Immunohistochemistry
1
Hyperthermia, Induced
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Oropharyngeal Neoplasms
×
Lidocaine
×
Clear all
NCT06747390
2026-05-12
856397
Abramson Cancer Center at Penn Medicine
Phase 1
Recruiting
30 enrolled